116 parallel-programming-"DIFFER"-"Mohammed-VI-Polytechnic-University" Fellowship positions at University of British Columbia in Canada
Sort by
Refine Your Search
-
benefits plan, including extended health and dental coverage Applications will be reviewed on a rolling basis until the position is filled. Please send application materials to travis.dewolfe@bccsu.ubc.ca
-
-year, with the potential to extend) Compensation: $60,000 per year Desired Start Date: April 1, 2025 Benefits: UBC offers a comprehensive benefits plan, including extended health and dental coverage
-
, or forest management. Project Overview The postdoc will contribute to the Silva21 research program, which aims to develop innovative strategies to enhance the resilience of Canadian forests in the face of
-
. Potential projects focus on severe ADRs to a range of different medications. Current priority ADRs include cisplatin-induced ototoxicity, anthracycline-induced cardiotoxicity, COVID-19 vaccine-induced
-
on the genetic determinants of severe adverse drug and vaccine reactions. Potential projects focus on severe ADRs to a range of different medications. Current priority ADRs include cisplatin-induced
-
of severe adverse drug and vaccine reactions. Potential projects focus on severe ADRs to a range of different medications. Current priority ADRs include cisplatin-induced ototoxicity, anthracycline-induced
-
with an aim towards independent research as well as good communication skills are also emphasized. If you want to innovate and make a difference in cancer care, this is the right place for you. Apply
-
emphasized. If you want to innovate and make a difference in cancer care, this is the right place for you. Apply today! Application: Interested candidates should include a CV, a complete list of past research
-
to research. Curiosity and creativity with an aim towards independent research as well as good communication skills are also emphasized. If you want to innovate and make a difference in cancer care, this is the
-
projects with a specific focus on the genetic determinants of severe adverse drug and vaccine reactions. Potential projects focus on severe ADRs to a range of different medications. Current priority ADRs